Methenamine Hippurate
Generic Name: methenamine hippurate
Brand Names:
Methenamine Hippurate
DESCRIPTION Each white to off-white capsule shaped tablet contains 1g Methenamine Hippurate, USP which is the Hippuric Acid Salt of Methenamine (hexamethylene tetramine). The tablet also contains inactive ingredients colloidal silicon dioxide, microcrystalline cellulose, magnesium stearate, povidone and sodium starch glycolate.
Overview
DESCRIPTION Each white to off-white capsule shaped tablet contains 1g Methenamine Hippurate, USP which is the Hippuric Acid Salt of Methenamine (hexamethylene tetramine). The tablet also contains inactive ingredients colloidal silicon dioxide, microcrystalline cellulose, magnesium stearate, povidone and sodium starch glycolate.
Uses
INDICATIONS Methenamine hippurate tablets, USP is indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug should only be used after eradication of the infection by other appropriate antimicrobial agents. To reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine hippurate tablets, USP and other antibacterial drugs, methenamine hippurate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
Dosage
DOSAGE AND ADMINISTRATION 1 tablet (1.0 g) twice daily (morning and night) for adults and pediatric patients over 12 years of age. 1/2 to 1 tablet (0.5 to 1 g) twice daily (morning and night) for pediatric patients 6 to 12 years of age. Since the antibacterial activity of methenamine hippurate tablets, USP is greater in acid urine, restriction of alkalinizing foods and medications is desirable. If necessary, as indicated by urinary pH and clinical response, supplemental acidification of the urine should be instituted. The efficacy of therapy should be monitored by repeated urine cultures.
Side Effects
ADVERSE REACTIONS Minor adverse reactions have been reported in less than 3.5% of patients treated. These reactions have included nausea, upset stomach, dysuria, and rash. To report SUSPECTED ADVERSE REACTIONS, contact Jubilant Cadista Pharmaceuticals Inc. at 1-800-313-4623 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Warnings
WARNING Large doses of methenamine (8 grams daily for 3 to 4 weeks) have caused bladder irritation, painful and frequent micturition, albuminuria, and gross hematuria. CONTRAINDICATIONS Methenamine hippurate tablets are contraindicated in patients with renal insufficiency, severe hepatic insufficiency, or severe dehydration. Methenamine preparations should not be given to patients taking sulfonamides because some sulfonamides may form an insoluble precipitate with formaldehyde in the urine.
Storage
HOW SUPPLIED Methenamine Hippurate Tablets USP, 1 g are white to off-white capsule shaped tablet, debossed with “L” and “59” on one side and break line (functional) on other side.
Frequently Asked Questions
What is Methenamine Hippurate used for?▼
INDICATIONS Methenamine hippurate tablets, USP is indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. This drug should only be used after eradication of the infection by other appropriate antimicrobial agents. To reduce the development of drug-resistant bacteria and maintain the effectiveness of methenamine hippurate tablets, USP and other antibacterial drugs, methenamine hippurate tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
What are the side effects of Methenamine Hippurate?▼
ADVERSE REACTIONS Minor adverse reactions have been reported in less than 3.5% of patients treated. These reactions have included nausea, upset stomach, dysuria, and rash. To report SUSPECTED ADVERSE REACTIONS, contact Jubilant Cadista Pharmaceuticals Inc. at 1-800-313-4623 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
What are the important warnings for Methenamine Hippurate?▼
WARNING Large doses of methenamine (8 grams daily for 3 to 4 weeks) have caused bladder irritation, painful and frequent micturition, albuminuria, and gross hematuria. CONTRAINDICATIONS Methenamine hippurate tablets are contraindicated in patients with renal insufficiency, severe hepatic insufficiency, or severe dehydration. Methenamine preparations should not be given to patients taking sulfonamides because some sulfonamides may form an insoluble precipitate with formaldehyde in the urine.
Related Medications
Allium Cepa Whole, Apis Mellifica, Aurum Metallicum, Borage, Bromus Ramosus, California Wildrose Whole, English Elm Ing Twig, English Hawthron, English Oak, European Hornbeam, European Olive, Gentianella Amarella, Gorse, Larix Decidua, Luffa Operculata, Mercurius Solubilis, Mullein, Natrum Muriaticum, Penstemon Davidsonii Whole, Platinum Metallicum, Pulsatilla Vulgaris, Purple Loosestrife Whole, Rosa Chinensis, Scotch Broom, Sepia, Wild Mustard, Yerba Santa, Zincum Metallicum
allium cepa whole, apis mellifica, aurum metallicum, borage, bromus ramosus, california wildrose whole, english elm ing twig, english hawthron, english oak, european hornbeam, european olive, gentianella amarella, gorse, larix decidua, luffa operculata, mercurius solubilis, mullein, natrum muriaticum, penstemon davidsonii whole, platinum metallicum, pulsatilla vulgaris, purple loosestrife whole, rosa chinensis, scotch broom, sepia, wild mustard, yerba santa, zincum metallicum
Standardized Insect Venom Allergenic Extract [EPC]
Uses: For temporary relief of minor: exhaustion* lack of endurance* apathy* easily discouraged* *Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Siponimod Hemifumarate
siponimod hemifumarate
Dosage form: POWDER. Active ingredients: SIPONIMOD (1 kg/kg). Category: BULK INGREDIENT.
Bartonella Bacilliformis, Bartonella Bacilliformis Dna, Bartonella Clarridgeiae, Bartonella Clarridgeiae Dna, Bartonella Elizabethae, Bartonella Henselae, Bartonella Henselae Dna, Bartonella Quintana, Bartonella Quintana Dna, Bartonella Vinsonii, Bartonella Vinsonii Dna, Bartonella Washoensis, Bartonella Washoensis Dna, Bartonella Elizabethae Dna
bartonella bacilliformis, bartonella bacilliformis dna, bartonella clarridgeiae, bartonella clarridgeiae dna, bartonella elizabethae, bartonella henselae, bartonella henselae dna, bartonella quintana, bartonella quintana dna, bartonella vinsonii, bartonella vinsonii dna, bartonella washoensis, bartonella washoensis dna, bartonella elizabethae dna
PURPOSE: Bartonella Bacilliformis - Malaise, Bartonella Bacilliformis DNA - Malaise, Bartonella Clarridgeiae - Chill, Bartonella Clarridgeiae DNA - Chill, Bartonella Elizabethae - Fever, Bartonella Henselae – Back Pain, Bartonella Henselae DNA – Back Pain, Bartonella Quintana – Head Pain, Bartonella Quintana DNA – Head Pain, Bartonella Vinsonii - Chills, Bartonella Vinsonii DNA - Chills, Bartonella Washoensis – Fever, Bartonella Washoensis DNA – Fever, DNA - Fever
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.